Cord Blood Banking Benefits with CBR


Your family means the world to you, and we’re here to help protect your family with preserving your newborn’s umbilical cord stem cells. That’s why we offer the Cord Blood Advantage program for our egg donor clients, through our sister company, Cord Blood Registry (CBR), the world's largest family newborn stem cell company.

How does it work?

Just report your pregnancy to qualify for FREE cord blood and cord tissue banking (a $2,830 value). After that, you just pay for annual storage of $180 per sample.* CBR is the leading choice of expectant families, as they are a pioneer in newborn stem cell collection and cryopreservation, CBR has helped over 500 families use their cord blood samples for established transplant medicine and experimental regenerative applications. It's just a quick phone call to get your account set up and get your collection kit for the big day.

Why are Newborn Stem Cells so interesting?

Newborn stem cells are a potentially powerful resource. We are excited about the future, which is why CBR partners with prominent research institutions on clinical trials exploring the use of cord blood stem cells for conditions that have no cure today. Here are a few reasons why we encourage your family to take a closer look at the future potential of your baby’s cord blood and cord tissue.

  • Natural approach: Newborn stem cells are smart and they “know” how to find injured cells and tissue in the body and initiate a healing process. In the future, this could be the body’s natural self-repair kit, helping the body heal itself. 1
  • Youthful cells: A newborn’s stem cells are young, flexible and more pristine than adult stem cells from other sources like bone marrow, and by preserving them now, you stop the clock and help protect them from aging and environmental exposures.2
  • Established therapies: Cord blood stem cells have been used for 30 years in the treatment of many serious diseases, such as certain blood cancers, immune and metabolic disorders, and hematologic conditions.
  • Bright future: There are more than 100 clinical trials underway around the world for both cord blood and cord tissue stem cells. These studies are researching a range of conditions, including transplant and regenerative medicine. 3

Ready to learn more about our Cord Blood Advantage Program?

Call us at (888) 280-8375, and our team of Newborn Stem Cell Educators can answer questions, walk you through your options, and help you get started today.

1. Meier C, Middlelanis J, Wasielewski B, et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res. 2006;59:244-249. 2. Gluckman E, Rocha V, Boyer-Chammard A, et al.; for Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med. 1997;337:373-381. 3. U.S. National Institutes of Health. website. Accessed November 2017.

*Annual storage rate may change in the future.